Helus Pharma Inc.(HELP)

Medical - Pharmaceuticals · Toronto, ON

$10.76-0.66 (-5.78%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

EBITDA Yield: N/A

Basis: Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The EBITDA yield is N/A as of 2026-10-06T21:51:55.603Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:51:55.603Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

TTM operating EBITDA · period ending 2026-06-30: -177,046,735
Quote market capitalization: 666,948,916
Total debt · period ending 2026-06-30: 0
Cash · period ending 2026-06-30: 166,165,362

FMP input reference: 934548bd97ab8c390298f716fcf622fc2d1107cfab085c47b2b47650fd31fbc6

EV/EBITDA|Earnings Yield|OCF Yield|FCF Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

HELP EBITDA Yield Metrics

EBITDA YIELD

N/A

HELP Competitors' EBITDA Yield

HELP

Helus Pharma Inc.

Current

Market Cap

$666.95M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MDXG

MiMedx Group, Inc.

vs HELP

Market Cap

$673.41M

EBITDA Yield

3.79%

TTM Avg

10.03%

3Y Avg

6.88%

5Y Avg

6.20%

ANNX

Annexon, Inc.

vs HELP

Market Cap

$660.29M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

STLN

Starling Oncology, Inc.

vs HELP

Market Cap

$657.89M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FDMT

4D Molecular Therapeutics, Inc.

vs HELP

Market Cap

$656.59M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VSTM

Verastem, Inc.

vs HELP

Market Cap

$681.02M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SLDB

Solid Biosciences Inc.

vs HELP

Market Cap

$681.27M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVR

Anteris Technologies Global Corp.

vs HELP

Market Cap

$685.49M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

OLMA

Olema Pharmaceuticals, Inc.

vs HELP

Market Cap

$691.79M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

FTH

Faeth Therapeutics, Inc.

vs HELP

Market Cap

$693.19M

EBITDA Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Helus Pharma Inc. (HELP)	$666.95M	N/A	N/A	N/A	N/A
MiMedx Group, Inc. (MDXG)vs ›	$673.41M	3.79%	10.03%	6.88%	6.20%
Annexon, Inc. (ANNX)vs ›	$660.29M	N/A	N/A	N/A	N/A
Starling Oncology, Inc. (STLN)vs ›	$657.89M	N/A	N/A	N/A	N/A
4D Molecular Therapeutics, Inc. (FDMT)vs ›	$656.59M	N/A	N/A	N/A	N/A
Verastem, Inc. (VSTM)vs ›	$681.02M	N/A	N/A	N/A	N/A
Solid Biosciences Inc. (SLDB)vs ›	$681.27M	N/A	N/A	N/A	N/A
Anteris Technologies Global Corp. (AVR)vs ›	$685.49M	N/A	N/A	N/A	N/A
Olema Pharmaceuticals, Inc. (OLMA)vs ›	$691.79M	N/A	N/A	N/A	N/A
Faeth Therapeutics, Inc. (FTH)vs ›	$693.19M	N/A	N/A	N/A	N/A

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EBITDA Yield: N/A

HELP EBITDA Yield Metrics

HELP Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics